LiDCO™ Monitoring System

 
TOUS
PRÉSENTÉ
TITRE
Multidisciplinary perioperative protocol in patients undergoing acute high-risk abdominal surgery.

Tengberg LT, Bay-Nielsen M, Bisgaard T, Cihoric M, Lauritsen MI, Foss NB. Br J Surg. 2017 Mar;104(4):463-471.

Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery.

Sadique Z, Harrison DA, Grieve R, Rowan KM, Pearse RM; OPTIMISE study group. Perioper Med (Lond). 2015;4:13. Published 2015 Dec 14.

Use of a pathway quality improvement care bundle to reduce mortality after emergency laparotomy.

Huddart S, Peden CJ, Swart M, et al. Br J Surg. 2015;102(1):57-66.

Effect of a peri-operative, cardiac output-guided, hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: A randomized clinical trial and updated systematic review.

Pearse et al. JAMA. 2014;311(21):2181-2190.

Reduced mortality with noninvasive hemodynamic monitoring of shock.

Hata J, Stotts C, Shelsky C, Bayman E, Frazier A, Wang J, Nickel E. J Crit Care. 2011;26(2):224.E1-8.

Association between perioperative fluid administration and postoperative outcomes: a 20-year systematic review and a meta-analysis of randomized goal-directed trials in major visceral/noncardiac surgery.

Messina, A., Robba, C., Calabrò, L. et al. Crit Care 25, 43 (2021).

Sustaining better care for patients undergoing emergency laparotomy.

Jordan, L.C., Cook, T.M., Cook, S.-C., Dalton, S.J., Collins, K., Scott, J. and Peden, C.J. (2020), Anaesthesia, 75: 1321-1330. https://doi.org/10.1111/anae.15088

Cross-comparisons of trending accuracies of continuous cardiac-output measurements: pulse contour analysis, bioreactance, and pulmonary-artery catheter.

Lamia B, Kim HK, Severyn DA, Pinsky MR. J Clin Monit Comput. 2018;32(1):33-43.

Multidisciplinary perioperative protocol in patients undergoing acute high-risk abdominal surgery.

Tengberg LT, Bay-Nielsen M, Bisgaard T, Cihoric M, Lauritsen MI, Foss NB. Br J Surg. 2017 Mar;104(4):463-471.

Reliability of cardiac output measurements using LiDCOrapid™ and FloTrac/Vigileo™ across broad ranges of cardiac output values.

Asamoto M, Orii R, Otsuji M, Bougaki M, Imai Y, Yamada Y. J Clin Monit Comput. 2017;31(4):709-716. doi:10.1007/s10877-016-9896-7

Effect of perioperative goal-directed hemodynamic therapy on postoperative recovery following major abdominal surgery-a systematic review and meta-analysis of randomized controlled trials.

Sun Y, Chai F, Pan C, Romeiser JL, Gan TJ. Crit Care. 2017;21(1):141. Published 2017 Jun 12.

Perioperative Goal-Directed Fluid Therapy is an essential element of an Enhanced Recovery Protocol.

Cannesson M, Gan TJ. Anesth Analg. 2016;122(5):1258-60.

A single surgeon's experience with Enhanced Recovery after Surgery: An Army of One.

Mosquera C, Koutlas NJ, Fitzgerald TL. Am Surg. 2016;82(7):594-601.

Application of LiDCO-Rapid in peri-operative fluid therapy for aged patients undergoing total hip replacement.

Han G, Liu K, Xue H, Zhao P. Int J Clin Exp Med 2016;9(2):4473-4478.

Effect of Perioperative Goal-Directed Hemodynamic Resuscitation Therapy on Outcomes Following Cardiac Surgery: A Randomized Clinical Trial and Systematic Review.

Osawa et al. Crit Care Med. 2016;44(4):724-33.

Enhanced Recovery after Surgery in a Single High-Volume Surgical Oncology Unit: Details Matter.

Fitzgerald TL, Mosquera C, Koutlas NJ, Vohra NA, Edwards KV, Zervos EE. Surg Res Pract. 2016;2016:6830260.

Propensity Score Analysis of an Enhanced Recovery Programme in Upper Gastrointestinal Cancer Surgery.

Karran A, Wheat J, Chan D, Blake P, et al. World J Surg. 2016;40:1645–1654. DOI 10.1007/s00268-016-3473-6A.

Goal-directed Fluid Therapy May Improve Hemodynamic Stability of Parturient with Hypertensive Disorders of Pregnancy Under Combined Spinal Epidural Anesthesia for Cesarean Delivery and the Well-being of Newborns.

Xiao W, Duan QF, Fu WY, et al. Chin Med J (Engl). 2015;128(14):1922-1931.

Use of a pathway quality improvement care bundle to reduce mortality after emergency laparotomy.

Huddart S, Peden CJ, Swart M, et al. Br J Surg. 2015;102(1):57-66.

Evaluation of the utility of the Vigileo FloTrac(™) , LiDCO(™) , USCOM and CardioQ(™) to detect hypovolaemia in conscious volunteers: a proof of concept study.

O'Loughlin E, Ward M, Crossley A, Hughes R, Bremner AP, Corcoran T. Anaesthesia. 2015;70(2):142-149.

Cost-effectiveness of a cardiac output-guided haemodynamic therapy algorithm in high-risk patients undergoing major gastrointestinal surgery.

Sadique Z, Harrison DA, Grieve R, Rowan KM, Pearse RM; OPTIMISE study group. Perioper Med (Lond). 2015;4:13. Published 2015 Dec 14.

Multimodal intraoperative monitoring: An observational case series in high risk patients undergoing major peripheral vascular surgery.

Green D, Bidd H, Rashid H. Int J Surg (2014);12(3):231-6. doi: 10.1016/j.ijsu.2013.12.016. Epub 2014 Jan 8.

Effect of a peri-operative, cardiac output-guided, hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: A randomized clinical trial and updated systematic review.

Pearse et al. JAMA. 2014;311(21):2181-2190.

Reduced length of hospital stay in colorectal surgery after implementation of an enhanced recovery protocol.

Miller et al. Anesth Analg 2014;118:1052–61.

Enhanced recovery in the resection of colorectal liver metastases.

Dunne DF, Yip VS, Jones RP, McChesney EA, et al. J Surg Oncol. 2014. doi:10.1002/jso.23616.

A cost-effectiveness analysis of postoperative goal-directed therapy for high-risk surgical patients.

Ebm C, Cecconi M, Sutton L, Rhodes A. Crit Care Med. 2014 May;42(5):1194-203.

Tackling the economic burden of postsurgical complications: would perioperative goal-directed fluid therapy help.

Manecke GR, Asemota A, Michard F. Crit Care. 2014;18(5):566. Published 2014 Oct 11. doi:10.1186/s13054-014-0566-1

Haemodynamic optimisation in lower limb arterial surgery: Room for improvement.

Bisgaard J, Gilsaa T, Ronholm E, Toft P. Acta Anaesthesiol Scand. 2013;57:189-198.

Impact of multidisciplinary standardized clinical pathway on perioperative outcomes in patients with oesophageal cancer.

Preston et al. Br J Surg. 2013;100(1):105-12. DOI: 10.1002/bjs.8974

Randomized clinical trial on enhanced recovery versus standard care following open liver resection.

Jones C et al. Br J Surg 2013 Jul;100(8):1015-24. Doi: 10.1002/bjs.9165.

Cost-effectiveness analysis of goal-directed hemodynamic treatment of elderly hip fracture patients: before clinical research starts.

Bartha E, Davidson T, Hommel A, Thorngren KG, Carlsson P, Kalman S. Anesthesiology. 2012;117(3):519-530.

Reduced mortality with noninvasive hemodynamic monitoring of shock.

Hata J, Stotts C, Shelsky C, Bayman E, Frazier A, Wang J, Nickel E. J Crit Care. 2011;26(2):224.E1-8.

Restrictive strategy of intraoperative fluid maintenance during optimization of oxygen delivery decreases major complications after high-risk surgery.

Lobo S et al. Crit Care. 2011;15:R226. doi:10.1186/cc10466.

Stroke Volume Variation as a Guide to Fluid Administration in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery.

Jain A & Dutta A. Obes Surg. 2010. DOI 10.1007/s11695-009-0070.

Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial.

Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED. Crit Care. 2005;9 (6):687-693.

Donnée clinique principale :

Indique un document PDF

Indique un résumé ou une présentation/indique un article de journal évalué par des pairs

Indique un article disponible gratuitement en téléchargement

Reproduire des résumés ou des publications est interdit

Ce chapitre est destiné à fournir un accès aux études cliniques réalisées à l'aide des technologies, paramètres et produits non invasifs de Masimo. Nous ne pouvons pas garantir que toutes les publications d'études cliniques, de résumés et de recherches sont répertoriées ici. Pour consulter les études cliniques individuelles, veuillez cliquer sur l'onglet approprié.

Certaines utilisations des appareils du fabricant décrites dans cette brochure peuvent ne pas avoir été approuvées ou validées par la FDA. Reportez-vous à l'étiquetage du fabricant pour les indications figurant dans les indications d'utilisation approuvées du produit.

Des preuves cliniques sont fournies pour illustrer les performances et la précision des technologies Masimo. La loi fédérale des États-Unis restreint la vente des dispositifs Masimo pour utilisations médicales par ou sur prescription d’un médecin.

PLCO-005077/PLMM-12050A-0521